Sign in
APLIF Stock Price, Chart, Stats & News
Appili Therapeutics Inc
Save
Appili Therapeutics Inc (APLIF) does not currently pay a dividend.
–
Market cap
–
Current P/E
1.66x
Forward P/E
APLIF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Appili Therapeutics, Inc. operates as a biopharmaceutical company, which acquires and develops novel treatments targeting unmet needs in infectious disease. It focuses on building and advancing a diverse portfolio of anti-infective programs such as ATI-1501, ATI-1503, and ATI-1701. The company was founded on May 7, 2015 and is headquartered in Halifax, Canada.
Similar securities
Based on sector and market capitalization
Report issue